Anticoagulation Options

View Sample PDF

Author(s): Michael Mazzeffi (University of Maryland, USA)and Ashleigh Lowery (University of Maryland, USA)
Copyright: 2015
Pages: 25
Source title: Modern Concepts and Practices in Cardiothoracic Critical Care
Source Author(s)/Editor(s): Adam S. Evans (Icahn School of Medicine at Mount Sinai, USA), Gregory E. Kerr (Weill Cornell Medical College, USA), Insung Chung (Icahn School of Medicine at Mount Sinai, USA)and Robin Varghese (Icahn School of Medicine at Mount Sinai, USA)
DOI: 10.4018/978-1-4666-8603-8.ch011

Keywords: Cardiovascular Medicine / Medical Diagnosis and Practice / Medical Information Science Reference / Medicine & Healthcare

Purchase

View Anticoagulation Options on the publisher's website for pricing and purchasing information.

Abstract

There are multiple indications for anticoagulation in the cardiac surgery intensive care unit including cardiac valve replacement, mechanical circulatory pumps (ECMO and ventricular assist devices), deep vein thrombosis prophylaxis, treatment of heparin-induced thrombocytopenia, and treatment of other thrombotic conditions including pulmonary embolism. Anticoagulant medications broadly fall into two categories: antiplatelet drugs and inhibitors of protein clotting factors. In this chapter we will review anticoagulant medications, therapeutic drug monitoring, common indications for anticoagulation, and the risks associated with anticoagulation after cardiac surgery.

The IRMA Community

Research IRM

Anticoagulation Options

Purchase

Abstract

Related Content

IRMA Sponsors